Novartis CEO defends $12 billion deal for Avidity as ‘appropriate risk to take’
By Bhanvi Satija LONDON (Reuters) -Swiss drugmaker Novartis on Monday defended its $12 billion deal to acquire Avidity Biosciences ahead…
Tag: Avidity
Keurig Dr Pepper Soars; Carter's Falls; Avidity Biosciences Rallies
On this episode of Stock Movers with Lisa Mateo: – Keurig Dr Pepper (KDP) shares soared ahead of the New…
Stock Movers: Nvidia, Avidity, Carter's (Podcast)
Source: Bloomberg, 4:11 www.bloomberg.com #Stock #Movers #Nvidia #Avidity #Carter039s #Podcast
Swiss drugmaker Novartis to buy Avidity Biosciences for $12 billion
Swiss drugmaker Novartis on Sunday said it agreed to acquire U.S. biotech firm Avidity Biosciences for about $12 billion in…
Novartis to acquire Avidity Biosciences for about $12 billion
By Padmanabhan Ananthan and Angela Christy M (Reuters) -Swiss drugmaker Novartis on Sunday said it agreed to acquire U.S. biotech…
Novartis Agrees to Buy Avidity Biosciences in $12 Billion Deal
Novartis AG agreed to buy biotechnology company Avidity Biosciences Inc. in a deal that values it at $12 billion, according…
Novartis Avidity Biosciences in talks
Signage for Novartis AG at a building in the company’s headquarters campus in Basel, Switzerland, on Monday, Jan. 8, 2023. …
Novartis Said to Near $70-Per-Share-Plus Deal for Avidity
Novartis AG is nearing a deal to buy biotechnology company Avidity Biosciences Inc., according to a person familiar with the…